1-7 of 7
Yukio Shigeta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy: The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

Free
Nigishi Hotta, MD, Yasuo Akanuma, MD, Ryuzo Kawamori, MD, Kempei Matsuoka, MD, Yoshitomo Oka, MD, Motoaki Shichiri, MD, Takayoshi Toyota, MD, Mitsuyoshi Nakashima, MD, Isao Yoshimura, PHD, Nobuo Sakamoto, MD, Yukio Shigeta, MD, the ADCT Study Group
Journal: Diabetes Care
Diabetes Care 2006;29(7):1538–1544
https://doi.org/10.2337/dc05-2370
Published: 01 July 2006
View articletitled, Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy: The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial
Open the PDF for Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy: The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial in another window
Journal Articles

Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for Diabetic Peripheral Neuropathy: A 52-week multicenter placebo-controlled double-blind parallel group study

Free
Nigishi Hotta, MD, Takayoshi Toyota, MD, Kempei Matsuoka, MD, Yukio Shigeta, MD, Ryuichi Kikkawa, MD, Toshio Kaneko, MD, Akira Takahashi, MD, Kimiya Sugimura, MD, Yasuo Koike, MD, Jun Ishii, MD, Nobuo Sakamoto, MD, The SNK-860 Diabetic Neuropathy Study Group
Journal: Diabetes Care
Diabetes Care 2001;24(10):1776–1782
https://doi.org/10.2337/diacare.24.10.1776
Published: 01 October 2001
View articletitled, Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for Diabetic Peripheral Neuropathy: A 52-week multicenter placebo-controlled double-blind parallel group study
Open the PDF for Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for Diabetic Peripheral Neuropathy: A 52-week multicenter placebo-controlled double-blind parallel group study in another window
Journal Articles

Effects of Troglitazone: A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy

Free
Yasuhiko Iwamoto, MD, Kinori Kosaka, MD, Takeshi Kuzuya, MD, Yasuo Akanuma, MD, Yukio Shigeta, MD, Toshio Kaneko, MD
Journal: Diabetes Care
Diabetes Care 1996;19(2):151–156
https://doi.org/10.2337/diacare.19.2.151
Published: 01 February 1996
View articletitled, Effects of Troglitazone: A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy
Open the PDF for Effects of Troglitazone: A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy in another window
Journal Articles

Development of Stable Film Test for Rapid Estimation of Blood or Plasma 3-Hydroxybutyrate

Free
Yutaka Harano, MD, PhD, Takahiko Aoki, MD, Yuzuru Nakajima, MD, Hideto Kojima, MD, PhD, Keisuke Kosugi, MD, PhD, Aki Harano, MD, Hideki Hidaka, MD, PhD, Shigeki Yamada, MS, Shizuo Uno, MS, Yukio Shigeta, MD, PhD
Journal: Diabetes Care
Diabetes Care 1990;13(5):522–524
https://doi.org/10.2337/diacare.13.5.522
Published: 01 May 1990
View articletitled, Development of Stable Film Test for Rapid Estimation of Blood or Plasma 3-Hydroxybutyrate
Open the PDF for Development of Stable Film Test for Rapid Estimation of Blood or Plasma 3-Hydroxybutyrate in another window
Journal Articles

Is Difference of Arterial and Venous Oxygen Content a Possible Marker for Diabetic Foot?

Free
Yasuo Kida, MD, Atsunori Kashiwagi, MD, Yoshihiko Nishio, MD, Mitsuyoshi Kodama, MD, Nanami Abe, MD, Yukio Shigeta, MD
Journal: Diabetes Care
Diabetes Care 1988;11(6):515–516
https://doi.org/10.2337/diacare.11.6.515
Published: 01 June 1988
View articletitled, Is Difference of Arterial and Venous Oxygen Content a Possible Marker for Diabetic Foot?
Open the PDF for Is Difference of Arterial and Venous Oxygen Content a Possible Marker for Diabetic Foot? in another window
Journal Articles

Improvement of Glucose Tolerance in NIDDM by Clofibrate Randomized Double-Blind Study

Free
Masashi Kobayashi, MD, Yukio Shigeta, MD, Yukimasa Hirata, MD, Yasue Omori, MD, Nobuo Sakamoto, MD, Seiki Nambu, MD, Shigeaki Baba, MD
Journal: Diabetes Care
Diabetes Care 1988;11(6):495–499
https://doi.org/10.2337/diacare.11.6.495
Published: 01 June 1988
View articletitled, Improvement of Glucose Tolerance in NIDDM by Clofibrate Randomized Double-Blind Study
Open the PDF for Improvement of Glucose Tolerance in NIDDM by Clofibrate Randomized Double-Blind Study in another window
Journal Articles

Development of Paper-strip Test for 3-Hydroxybutyrate and its Clinical Application

Free
Yutaka Harano, M.D., Masaaki Suzuki, M.D., Hideto Kojima, M.D., Atsunori Kashiwagi, M.D. Ph.D., Hideki Hidaka, M.D. Ph.D., Yukio Shigeta, M.D. Ph.D.
Journal: Diabetes Care
Diabetes Care 1984;7(5):481–485
https://doi.org/10.2337/diacare.7.5.481
Published: 01 September 1984
View articletitled, Development of Paper-strip Test for 3-Hydroxybutyrate and its Clinical Application
Open the PDF for Development of Paper-strip Test for 3-Hydroxybutyrate and its Clinical Application in another window